2021 FDA Approval Trade

INO.com

The below offer is brought to you by Legend Research

Private investor who delivered his clients Moderna (MRNA) @ $25
is offering you his 2021 FDA Approval Trade

Trading Forex,

Once a year, the founder of Legend Research sends out his "Trade of the Year." This pending FDA approval trade that looks to send this $1.25 option soaring once the FDA puts it's stamp on it.

This is a 100% Completely FREE Offer.

To access the trade, click here.

Sincerely,
Legend Research

To accept this special invitation, click here.

 
Indexes Snapshot
Symbol Last Change %
Dow Jones Industrial Average 30924.14 -345.95 -1.12%
NASDAQ Composite 12723.47 -274.28 -2.16%
S&P 500 3768.47 -51.25 -1.36%
SPDR S&P 500 376.20 -5.22 -1.39%
iShares Russell 2000 ETF 213.200 -6.120 -2.87%
U.S. STOCK INDEXES

The Dow closed sharply lower on Thursday and closed below the 50-day moving average crossing at 30,947.95 confirming that a short-term top has been posted. Today's sell off came close to erasing this year-to-date gains as today's sell-off gained momentum, following comments from Federal Reserve Chairman Jerome Powell. The low-range close sets the stage for a steady to lower opening when Friday's night session begins trading. Stochastics and the RSI are turning neutral to bearish again signaling that sideways to lower prices are possible near-term. If the Dow extends the decline off February's high, January's low crossing at 29,856.30 is the next downside target. If the Dow resumes the rally off January's low into uncharted territory, upside targets hard to project. First resistance is February's high crossing at 32,009.64. Second resistance is unknown. First support is today's low crossing at 30,547.53. Second support is January's low crossing at 29,856.30.

The March NASDAQ 100 closed lower for the third day in a row on Thursday as it extends the decline off February's high. The mid-range close sets the stage for a steady to lower opening when Friday's night session begins trading. Stochastics and the RSI are oversold but remain neutral to bearish signaling that sideways to lower prices are possible near-term. If March extends the decline off February's high, the December 10th low crossing at 12,217.00 is the next downside target. Closes above the 20-day moving average crossing at 13,367.58 would signal that a short-term low has been posted. First resistance is the 20-day moving average crossing at 13,367.58. Second resistance is February's high crossing at 13,900.50. First support is today's low crossing at 12,306.50. Second support is the December 10th low crossing at 12,217.00.

The March S&P 500 closed lower on Thursday and below the 50-day moving average crossing at 3813.02 confirming that a short-term top has been posted. The mid-range close sets the stage for a steady to lower opening when Friday's night session begins trading. Stochastics and the RSI are turning neutral to bearish signaling that sideways to lower prices are possible near-term. If March extends today's decline, February's low crossing at 3656.50 is the next downside target. Closes above the 20-day moving average crossing at 3882.00 would signal that a short-term low has been posted. First resistance is the 20-day moving average crossing at 3882.00. Second resistance is February's high crossing at 3959.25. First support is today's low crossing at 3720.50. Second support is February's low crossing at 3656.50.



Thank you!

Thank you for subscribing to Market Commentary from INO.com.

You can modify your email preferences or unsubscribe here.

INO.com, Inc. | 228 Park Avenue South, Suite 320 | New York, New York 10003

U.S. Government Required Disclaimer - Commodity Futures Trading Commission Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results

These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown.

All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher or INO.com. No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the methodology or system will generate profits or ensure freedom from losses. The testimonials and examples used herein are exceptional results, which do not apply to the average member, and are not intended to represent or guarantee that anyone will achieve the same or similar results. Each individual's success depends on his or her background, dedication, desire, and motivation.

Comments

Popular posts from this blog

AllBusiness.com

Do not trade options until you read this

7 Best Stocks for the Next 30 Days - Free from Zacks Investment Research